Article
Healthy B cells: allies or adversaries of CAR-T cell immunotherapy?
2024-11-11
Abstract excerpt
Chimeric antigen receptor (CAR)-T cell immunotherapy has achieved significant success against various haematological cancers, including B-cell malignancies. Its efficacy against B-cell cancers is influenced by the presence of healthy B-cells expressing the target antigen, and B-cell aplasia (BCA) serves as an indicator of successful therapy outcome. However, the precise influence of healthy B-cells on the in vivo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 571b6ec9-ab40-5287-b6ef-a467fe226140
- DOI
- 10.1101/2024.11.08.622644
